Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275545 · ClinicalTrials.gov registry record
Neural Correlates of Reward and Symptom Expression in Anorexia Nervosa
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 79
- Enrollment target
NCT03275545: Completed study, sponsored by University of Minnesota.
NCT03275545 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03275545 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The objective of this study is to identify the patterns of brain activity in reward circuitry that promote symptoms of anorexia nervosa. This project will compare weight-restored individuals with anorexia nervosa to a non-eating disorder control group on reward brain circuitry patterns in response to typically rewarding cues (i.e., entertaining videos) and disorder-specific restrictive eating cues (i.e., low-fat food choice) using fMRI. In addition, this study will examine which neurobiological reward responses among weight-restored individuals with anorexia nervosa predict objective restrictive eating (measured by laboratory meal intake) and longitudinal risk of relapse one year later.
Primary Outcome
Activation in regions of interest in reward brain circuitry (i.e., ventral tegmental area, nucleus accumbens) in response to typically-rewarding and disorder-specific tasks
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-02-28 |
| Est. Completion | 2022-08-01 |
What the finished NCT03275545 record still lists
NCT03275545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT03275545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03275545 about?
NCT03275545 is a clinical study titled "Neural Correlates of Reward and Symptom Expression in Anorexia Nervosa". The objective of this study is to identify the patterns of brain activity in reward circuitry that promote symptoms of anorexia nervosa. This project will compare weight-restored individuals with anorexia nervosa to a non-eating disorder control group on reward brain circuitry patterns in response t...
What is the current status of trial NCT03275545?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2018-02-28. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT03275545?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT03275545?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI